Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
129 Cards in this Set
- Front
- Back
Factors stimulating Th1 development |
IL-12 by dendritic cells, influences IFN-gamma production by NK cells |
|
Transcription factor for Th1 cells |
TBet |
|
Tbet turns on expression of what genes |
IFN-gamma |
|
Th1 cells secrete what |
IL-2 IFN-gamma |
|
Pathogenstrigger tissue macrophages or DCs to secrete... |
IL-1 and TNF-alpha |
|
What do IL-1 and TNF-alpha do |
Upregulate E- and P-selectin Upregulate ICAM-1 and VLA-4 on endothelial cells which line the blood vessel |
|
What is the purpose of upregulation of selectins and LFA-1 ligands? |
"Mark" the infected territory |
|
Purpose of chemokines |
|
|
CD4 effector cells Production of TNF-alpha, IFN-gamma, and TNF-beta does what |
Activates macrophages |
|
CD4 effector cells Production of TNF-alpha and CCL-2 does what |
Activate endothelial cells |
|
CD4 effector cells Production of IL-3 and GM-CSF |
Act on Progenitor Cells in marrow Increases Numbers of Macrophages / Dendritic Cells |
|
Co-stimulatory molecule in CD4 - macrophage interaction |
CD40 / CD40L |
|
Th1 cells secrete what to activate macrophages |
IFN-gamma |
|
Consequences of macrophage activation |
1. Phagosome fusion with lysosome efficiency increased 2. Increased levels of lysosomal enzymes 3. Increase in antimicrobial molecules |
|
ChronicGranulomatous Disease caused by mutations in ___________ Causes ___________ |
NADPH proteins Inability to clear pathogens, chronic stimulation of T cells --> granulomas |
|
Enzyme used by foreign organisms to degrade superoxide radicals |
Catalase |
|
Ligand halting immune response |
CTLA-4 |
|
Two major ways memory T cells differ from naive T cells |
Memory cells circulate, naive in lymph nodes Memory have less stringent activation requirements |
|
In an adult what percentage of T cells are memory |
About 50% |
|
Two types of T Memory cells |
Effector Memory and Central Memory |
|
Major CDs for T cell homing to lymph nodes |
CD62L, CCR7 |
|
Effector memory T cells |
CD62L/CCR7 negative Circulate in tissues When stimulated by antigen, differentiate into effector secreting IFN-gamma, I-4, IL-5 |
|
Central memory T cells |
CD62L/CCR7 positive Upon stimulation, express CD40L Help B cells |
|
Differences in expressed surface molecules between TM and TE/TN |
Decreased CD62L / CCR7 Increased CD44 CD45RO vs CD45RA (naive) Increased bcl-2 Increased CD127 |
|
What is bcl-2 |
Prevents apoptosis |
|
Difference between CD45RO and RA |
CD45RO more closely associated with CD4 or 8 RO has phosphatase which removes the phosphate on CD 4/8 keeping lck from being activated |
|
Cytokines involved in T memory cell proliferation without presence of antigen |
IL-7, IL-15 |
|
Transcription factor for differentiation into TReg |
FoxP3 |
|
TReg receptor for IL-2 |
CD25 |
|
Molecules identified on the surface(or secreted) of TRegcells associated with effectorfunctions |
CTLA-4, TGF-beta, IL-10 |
|
Defect in FoxP3 causes |
lethal autoimmunity |
|
Gamma/delta T cells express receptors depending on |
What compartment they're in |
|
Vγδ1 receptor recognizes |
MIC-A and MIC-B |
|
Do NK cells have TCRs? |
No |
|
What antigens do NK cells recognize |
Viral, MIC-A, MIC-B |
|
What antigens do NKT cells recognize |
Lipids presented on CD1d |
|
What antigens does Vγ9Vδ2 recognize |
Metabolic products of invaders |
|
Do NK rearrange immunoglobulin genes or receptor genes? |
No |
|
Defining cell surface protein of NK cells |
CD56 Low expression predominate in blood High expression in lymphoid tissue |
|
How are NK cells different from Tcells? |
Larger Have granules (immediate readiness) NO TCR No memory response |
|
Virally-infected cells produce _________ which starts NK cell proliferation |
IFN-a and IFN-b |
|
People who lack NK cells suffer from persistent |
viral infections, especially herpes |
|
Macrophages activate NK cells by producing |
IL-12 TNF-a IL-15 |
|
Major function of NK-secreted IFN-gamma |
activate TBET transcription factor in CD4 cells |
|
Positive feedback system between NK cells and macrophages |
NK cells --> IFN-gamma Macrophages --> IL-12 |
|
TNF-a induces |
inflammation |
|
NK cell receptor that binds to MIC-A and MIC-B |
NKG2D |
|
Two structural types of NK receptors |
Immunoglobulin-like and lectin-like |
|
What are MIC-A and MIC-B |
Cell surface proteins produced in response to stress |
|
Inhibitory signals to NK cells delivered by |
HLA-E HLA-A, B, C |
|
What NK receptor recognizes HLA-E |
CD94:NKG2A |
|
HLA-E binds to what |
Degraded leader peptides of HLA-A, B, and C heavy chains |
|
The amount of HLA-E on a cell surface is indicative of |
The amount of HLA-A, B, and C being made by the cell |
|
Do all NK cells have the same KIRs |
No, each NK cell expresses a random subset of KIR genes, creastes enormous diversity |
|
KIRs recognize what |
Polymorphic determinants on HLA-A, B, and C |
|
Is the absence of a negative signal enough to stimulate an NK cell |
No, needs to have a positive signal |
|
What does CD1 do |
Presents lipid antigens produced by organisms such as mycobacteria In the absense of these, self lipids |
|
What cells express CD1 |
Cells that can be infected with mycobacteria ie dendritic cells |
|
What cells express CD1d |
Epithelial cells in many tissues |
|
CD1d presents antigen to |
NKT cells |
|
What receptors do NKT cells have |
a:b TCR and NK receptors |
|
Mismatchedbone marrow cell transplants are a problem because |
They are allogeneic cells which by definition can express different MHC class I molecules Get attacked by NK cells |
|
NK cells can recognize and kill human cells coated with |
IgG1 or IgG3 |
|
Why can antibody-dependent cell-mediated cytotoxicity (ADCC) only occur at a late stage in the primary immune response? |
Because class-switching to IgG must occur. Faster in secondary responses. |
|
NK receptor for FC portion of IgG1 and IgG3 |
FcγRIII (CD16) |
|
Placental NK cells |
Trophoblasts secrete HLA-E, induces NK cells to produce factors that promote vessel growth in placenta |
|
Where are B lymphocytes formed |
Fetal: liver and spleen Adult: Bone marrow |
|
Half life of a B cell |
3-8 weeks |
|
Cells with the potential of becoming a B or T lymphocyte |
Common lymphoid progenitor CLP |
|
Main event of Pro-B stage |
Rearrangement of heavy chain genes |
|
A B cell is "early pre-B" once it expresses |
Mu heavy chain |
|
How many times can a pro-B cell rearrange its heavy chain? |
Twice - each has two copies of the heavy chain locus, one inherited from mom and one from dad. If both nonproductive, cell dies |
|
Genes involved in heavy chain rearrangements |
RAG1 and RAG2 |
|
Two criteria a B cell must satisfy to survive |
Makes a functional mu heavy chain Heavy chain must combine with a light chain |
|
How are B cell heavy chains tested? |
VpreB and lambda-5 bind to the heavy chain in similar manner to light chains "Pre-B cell receptor" |
|
Assembly of a heavy chain + surrogate light chain causes expression of what to stop |
RAG enzymes |
|
When do RAG enzymes reappear in B cell development |
Late pre-B |
|
Key growth factors for B cells expressed by stromal cells |
IL-7 (IL-7R) Stem Cell Factor (ckit, receptor gone when Pre BCR comes) |
|
Immature B cells express what on their surface |
IgM |
|
As B cells mature what do they display on their surface |
IgM and IgD |
|
How do developing B cells deal with sensitivity to self-antigen? |
1. If strong specificity, apoptosis 2. If moderate sensitivity, rearranges light chain (receptor editing) |
|
What surface protein defines B1 cells |
CD5 |
|
B1 cells mostly produced during the _____ period |
fetal |
|
B1 cells in adults mostly found where |
Peritoneal and pleural cavities |
|
B1 cells detect what |
PAMPs, poor specificity for proteins |
|
B1 cells are a major source for what disease |
CLL bc constant renewal can lead to genetic error |
|
Where are marginal zone b cells found |
Marginal sinus of white pulp in spleen |
|
What surface receptors are on MZ b cells |
CD21/35 C3 fragment complement receptors |
|
Splenectomy patients lack what population of B cells |
Marginal zone |
|
MZ b cells have a biased BCR repertoire to |
common environmental bloodborne antigens |
|
Where are T cell progenitors produced |
Fetal: Liver --> thymus in 8-9 wk gestation Neonate: Bone marrow --> thymus |
|
Definitive surface markers of T cells |
TCR, CD3 |
|
Regions of thymus |
Subscapular: committment Cortex: TCR positive/negative selection Medulla: Negative selection, maturation |
|
DiGeorge syndrome |
Thymic aplasia Defect in neural crest Suboptimal to absent production of T cells |
|
Percentage of T cells that are DN DP SP |
DN: 5% DP: 80% SP: 15% |
|
Developing T cells are DN in what thymus region |
subcapsular (7-14 days) |
|
Developing T cells are DP in what thymus region |
Cortex and cortico-medullary junction (4 days) |
|
Developing T cells are SP in what thymus region |
Medulla (7 days) |
|
What can be used to stage developing T cells |
CD4 / CD 8 expression |
|
Critical cytokine in T cell development |
IL-7, turns on RAG |
|
Commitment to alpha-beta chain lineage requires _______ rearrangement whereas gamma-delta requires _______ |
one; two |
|
TCRg/d T cells found mainly in |
Epithelial cell surfaces, GI, reproductive tracts |
|
What happens after successful rearrangement of the beta chain of T cells |
Suppression of RAG Proliferation to DP thymocytes |
|
X-SCID is due to |
Failed IL-7 signaling during development --> no T Failed IL-4 and IL-21 --> no B cell class switching |
|
Treatment of XSCID |
Bone marrow transplant Gene therapy |
|
What is positive selection in relation to T cells |
Permitting survival of T cells that can recognize self-MHC |
|
What is negative selection in relation to T cells |
•Eliminates T cells that react too strongly with self-MHC molecules and self-antigen presented by self-MHC. |
|
Factor that suppresses CD8 production on an MHC-II recognizing T cell |
Th-PoK |
|
Factor that suppresses CD4 production on an MHC-I recognizing T cell |
Runx3 |
|
Negative selection of T cells mostly mediated by |
Dendritic cells and macrophages presenting self-antigens |
|
Cells expressing proteins from other tissues to show to developing T cells |
Thymic medullaryepithelial cells that express autoimmune regulator (AIRE) |
|
Surface factors of Effector CTL cells |
Reduced CD62L Presence of ICAM-1 and VLA-1 Increased CD2 |
|
Cytotoxic T cells produce mainly |
cytotoxins |
|
_______ are the most effective APCpopulation for delivering signals to activate naïve CD8 T cells. |
Dendritic cells |
|
Signal 1 and signal 2 for naive CD8 cells |
TCR - MHC:peptide CD28 - B7 |
|
How do CD4 Th1 cells help CD8 cells? |
Increase expression of B7 on APCs Production of IL-2 |
|
Lytic granules of cytotoxic cells |
Granzymes, perforin and granulysin |
|
Granzyme pathway of destruction |
Cd8 cells release contents of lytic granules (perforin and granzymes form a multimeric complex with serglycin and granulysin). Poresare generated in target cell membrane. Granzymes,perforin, granulysin (human) enter target cell. Thecytotoxic cell disengages. |
|
Necrosis v Apoptosis |
Necrosis: No DNA fragmentation, leakage of cell contents, inflammation Apoptosis: DNA cleavage, plasma membrane blebbing |
|
How is DNA cleaved in granzyme pathway |
Granzyme activates caspase 3 --> cleavage of ICAD inhibitor of CAD (Caspase Activatable DNAase) |
|
Targets of caspase 3 |
Cleave and disable inhibitor of Caspase Activatable DNAase (ICAD) Inhibit lamin proteins (cell integrity) Inhibit nuclear repair enzymes |
|
Mitochrondria in apoptosis |
Swell and leak cytochrome c --> bind to APAF --> activation of pro-caspase 9+3 --> cleavage of ICAD |
|
Bax, Bok, Bak |
Form pores in mitrochondria |
|
Bad, bid, puma |
Inhibit bcl |
|
BcLs |
Inhibit apoptosis |
|
Two death pathways of CTLs |
1.Perforin / Granzyme exocytosis pathway 2.Death Ligand – Death Receptor Pathways |
|
What is the FasL-Fas pathway |
Fas ligand binds to Fas, causes conformational change in death domains inside cell. FADD binds to DDs, recruits caspases 8 and 3. Caspase 3 cleaves ICAD. |
|
Homotryptic dimer initiating an apoptotic pathway |
Fas |
|
Fas-FasL pathway most important for |
controlling proliferation of lymphocytes |